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Serogroup  B outer  membrane  vesicles  (OMV)  with  iron  regulated  proteins  (IRP)  from Neisseria  meningitidis
constitute  the  antigen  for  the  vaccine  against  the disease  caused  by this  bacterium.  Aiming  to enhance
ﬁnal  OMV  concentration,  seven  batch  experiments  were  carried  out  under  four  different  conditions:  (i)
with  original  Catlin  medium;  (ii)  with  original  Catlin  medium  and  lactate  and  amino  acids  pulse  at  the 6th
cultivation  hour;  (iii)  with  Catlin  medium  with  double  initial  concentrations  of  lactate  and  amino  acids
and  (iv)  Catlin  medium  without  glycerol  and  with  double  initial  concentrations  of lactate  and  amino
acids.  The  cultivation  experiments  were  carried  out in  a 7-L bioreactor  under  the  following  conditions:
36 ◦C,  0.5  atm,  overlay  air  1  L/min,  agitation:  250–850  rpm,  and  O2 control  at 10%,  20  h.  After  lactateaccine
ioreactor  systems
inetics
and  amino  acids  exhaustion,  cell  growth  reached  stationary  phase  and  a  signiﬁcant  release  increase  of
OMV  was  observed.  According  to  the  Luedeking  &  Piret  model,  OMV  liberation  is non-growth  associated.
Glycerol  was  not  consumed  during  cultivation.  The  maximum  OMV  concentration  value  attained  was
162  mg/L  with  correspondent  productivity  of  8.1  mg/(L  h)  employing  Catlin  medium  with  double  initial
concentrations  of  lactate  and  amino  acids.  The  obtained  OMV  satisﬁed  constitution  and  protein  pattern
 for  vcriteria  and  were  suitable
. Introduction
Meningitidis and sepsis caused by serogroup B meningococcus
re two severe diseases that continue to cause signiﬁcant mortality
1,2].
Five major pathogenic serogroups have been identiﬁed on the
asis of the chemical composition of the bacterial capsule (A, B, C,
 and W135) [3–5].
However,  the capsular vaccine approach is not suitable for
trains of serogroup B since that polysaccharide capsule has a struc-
ural homology to human embryonic neural tissue [6]. Thus, outer
embrane proteins or outer membrane vesicles (OMV)-based vac-ines were tested extensively in clinical trials [7].
An  alternative approach to vaccine development is based on
urface-exposed proteins contained in outer membrane vesicles
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[4,8,9]. OMV  are released from the outer membrane of Gram
negative bacteria. They consist of a phospholipid (PL) bilayer
containing outer membrane proteins, lipopolysacchharide (LPS)
and periplasmic constituents [10]. These vesicles are made up of
ﬁve major proteins. Besides, there is the protein NadA and, depend-
ing on the conditions of cultivation, the iron regulated proteins (IRP)
[11–13].
Furthermore, it is worth mentioning that OMV  are also
employed as carriers of polysaccharides in conjugated vaccines
against Haemophilus inﬂuenzae and in vaccines against pneumo-
nia [14,15]. A common antimeningococcal vaccine project against
meningitis B and C had proposed a vaccine containing outer mem-
brane vesicles (OMV) from Neisseria meningitidis B expressing iron
regulated proteins (IRP) from a strain with high incidence in Brazil
(N 44/89). The lipooligosaccharide (LOS endotoxin) of OMV  is high
toxic. However residual LOS amounts are needed to maintain vesi-
cle structure and adjuvate the immune response.
Many studies have been carried out previously on other aspects
of vaccine development, such as: the production process of N.
Open access under the Elsevier OA license.meningitidis C [16–18]; the evaluation of the importance of a sec-
ond serogroup B strain as vaccine component [19]; the obtainment
of vesicles with appropriate characteristics (with IRP expression
and with low level of LOS) [20,21]; and the conjugation process
S. Santos et al. / Vaccine 30
Nomenclature
O.D. optical density
Pmax maximum OMV  concentration (mg/L)
ProdP OMV  productivity (mg/(L h))
ProdX biomass productivity (g/(L h))
t cultivation time (h)
Xmax maximum cell concentration (g/L)
YX/S yield factor biomass/lactate (g/g)
YP/X yield factor OMV/biomass (mg/g)
˛ growth associated coefﬁcient (g/g)
ˇ non-growth associated coefﬁcient (g/(g h))






























oX speciﬁc growth rate (h−1)
f N. meningitidis C polysaccharide with N. meningitidis B OMV
22,23].
The objective of this study was to investigate the N. meningitidis
erogroup B for bacterial growth, consumption of carbon and nitro-
en as substrates, OMV  production kinetics, and the composition
nd morphology of the released OMV. The study also aimed the
ncreasing of OMV  yield and the employment of the generated data
or further experiments relative to the development and scaling up
f the vaccine production process.
. Materials and methods
.1.  Process conditions
The  inoculum of N. meningitidis B strain N44/89 (Instituto
dolpho Lutz, São Paulo, Brazil) was prepared according to
otschlich et al. [24]. The inoculum, Catlin medium without iron
upplementation and 7-L bioreactor preparation were described in
revious work [25].
.2.  Analytical methods
Cell  concentration was expressed as optical density at 540 nm
nd dry biomass weight per liter (g/L) after centrifugation of a
nown-volume sample at 3220 × g for 30 min, followed by pel-
et drying at 60 ◦C for 48 h. Glycerol concentration measurement
26] was based on oxidation of glycerol by sodium periodate. The
ormic acid generated was titrated with a NaOH solution (0.125 N)
nd the volume consumed corresponded to the glycerol concen-
ration. Glycerol concentrations were also conﬁrmed by HPLC,
odel 10AVP (Shimadzu, Kyoto, Japan) using an HPX-87H col-
mn (Bio Rad, Hercules, CA, USA) after dilution of samples (1:5).
 5.0 mM sulfuric acid solution was used as mobile phase under
able 1
alues of maximum cell concentration (Xmax), maximum OMV concentration (Pmax), biom
YX/S), OMV/biomass (YP/X), speciﬁc product formation rate (P) and non-growth associat
Series Run number Stationary phase
beginning  (h)
Xmax (g/L) Pmax (mg/L) Prod
A 1 6 0.58 55.2 0.10
2  6 0.57 44.2 0.09
B  3 10 0.98 59.4 0.10
4  10 1.39 65.9 0.14
C  5 10 1.67 162 0.17
6 9 1.22  157 0.14
D  7 12 2.27 121 0.19
 – original Catlin medium; B – original Catlin medium with lactate and amino acids puls
f lactate and amino acids; D – Catlin medium without glycerol and with double initial co (2012) 6064– 6069 6065
ﬂow  rate of 0.6 mL/min. Lactate concentrations were determined
employing an automatic enzymatic analyzer (Yellow Spring, model
YSI 2700 Select, Yellow Springs, OH, USA). OMV  were separated
from supernatant cultivation after ultracentrifugation (Beckman,
L8-M Ultracentrifuge, Palo Alto, CA, USA) of 50 mL  samples at
30,000 rpm for 3 h. The obtained OMV  were resuspended in 0.5 mL
of 0.02% sodium azide. The amino acids concentrations were deter-
mined by HPLC, model 10AVP (Shimadzu, Kyoto, Japan) employing
Ultrasphere C-18 column (Beckman, Palo Alto, CA, USA). Pro-
tein concentrations in the OMV  resupensions were estimated by
Lowry’s method [27]. In order to verify IRP presence electrophore-
sis method was  employed [28]. OMV  were separated by SDS-PAGE
(10% acrylamide/bisacrylamide gel) and the gel was stained with
0.1% Coomassie blue. The expression of IRP in the fractionated OMV
extracts was estimated by the presence of 70–108 kDa bands [29].
For electronic microscopy, the negative contrast technique was
employed. An OMV  suspension contained in 15 L of PBS, pH 7.2
was applied onto a parlodium/carbon coated 300 meshes copper
grids during 2 minutes. The excessive ﬂuid was  removed from the
grids and negative staining was carried out employing phospho-
tungstic acid 2%, pH 7.2 during 10 seconds. The grids were then
examined under a transmission electronic microscope LEO 906E
(Zeiss, Germany) operated at 80 kV with digital image capture sys-
tem coupled.
3.  Results
The main results of the batch tests are summarized in Table 1. All
the experiments were carried out without iron supplementation.
The experiments were classiﬁed in four series, as shown in Table 1
– Series A: original Catlin medium; Series B: original Catlin medium
with lactate and amino acids pulsed at 6th hour of cultivation; Series
C: Catlin medium with double initial concentrations of lactate and
amino acids; Series D: Catlin medium without glycerol and with
double initial concentrations of lactate and amino acids.
Typical  growth curves of runs 1–7 are shown in Fig. 1a and the
corresponding produced OMV  in Fig. 1b. The behavior of pH vari-
ation and glycerol concentrations during cultivation are presented
in Fig. 1f and e, respectively. The lactate and l-glutamic acid con-
sumptions are shown in Fig. 1c and d, respectively. From these
behaviors, it is evident that substrate consumption exerted remark-
able inﬂuence on growth kinetics and OMV  production. The analysis
of the related dry mass and optical density indicated an average
value of 0.46 g/L for each unit of O.D. (SD 0.06). This coefﬁcient was
employed for estimating dry biomass values from the O.D. values
and for calculating P.According to the kinetics parameters presented in Table 1,
the assays of Series A and B (original Catlin medium and origi-
nal Catlin medium with lactate and amino acids pulse at the 6th
cultivation hour, respectively) presented similar values of OMV
ass productivity (ProdX), and OMV  productivity (ProdP), yield factor biomass/lactate
ed empirical constant (ˇ) for the experiments 1–7.
X (g/(L h)) ProdP (mg/(L h)) YX/S (g/g) YP/X (mg/g)  ˇ = p (g/(g h))
 3.06 0.24 95.4 2.63
 2.21 0.23 78.1 1.11
 2.97 0.43 60.8 4.28
 3.86 0.61 47.3 8.99
 8.12 0.78 97.3 22.41
 7.85 0.47 129 24.51
 6.05 0.38 53.3 16.06
ed at 6th hour of cultivation; C – Catlin medium with double initial concentrations
ncentrations of lactate and amino acids.























































































































ﬁig. 1. Kinetics curves of bacterial growth (a), OMV  production (b), l-lactate consu
atlin medium; run 3 (): original Catlin medium with lactate- and amino acids pu
f lactate and amino acids; and run 7 (©): Catlin medium without glycerol and withaximum concentration (Pmax) and OMV  productivity (ProdP) for
hese two groups. However they were the lowest ones considering
he overall experimental results. Series A and B presented, respec-








































ig. 2. Kinetics curves for Series A (original Catlin medium): dry biomass (), lactate (), l
gure on the right represents substrate scale zoom-out of the ﬁgure on the left in order tn (c), l-glutamic acid consumption (d), glycerol (e), and pH (f). Run 1 (♦): original
t 6th cultivation hour; run 6 (): Catlin medium with double initial concentrations
le initial concentrations of lactate and amino acids.On  the other hand, Series C experiments (Catlin medium, dou-
ble initial concentrations of lactate and amino acids) presented
the highest values of these parameters, namely Pmax = 162 g/L





































-glutamic acid ( ), l-glicine (♦), l-serine (×), l-cisteine (©) and l-arginine ( ). The
o visualize better marginal amino acids consumption.







































Fig. 3. SDS-PAGE gel electrophoresis of OMV  samples obtained in experiment 5 of
Series C (Catlin medium with double initial concentrations of lactate and amino
acids).  The columns numbered 6–20 correspond to the fractionated OMV  extract
F
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Fig. 1e). In Series D (Catlin medium, without glycerol, double
nitial concentrations of lactate and amino acids), the values of
max = 121 g/L and ProdP = 6.0 mg/(L h) were slightly better than
ther those from Series C. The highest OMV  concentrations were
btained in Series C (where initial glycerol concentration was main-
ained and the initial concentrations of amino acids and lactate
oubled) (Fig. 1c and d, run 6). Glycerol was not consumed in culti-
ations [25], so it has no direct inﬂuence on the OMV  production. A
lausible hypothesis is that glycerol could be the mechanical pro-
ector of the OMV  released to the cultivation medium. Lactate is
he main limiting carbon source while l-glutamic acid is the main
imiting nitrogen source (Figs. 1c, d and 2). l-Glutamic acid con-
umption contributes to ammonia formation and pH rising in the
ourse of the cultivation (Fig. 1f). By employing the original Catlin
edium (Series A) lactate concentration decreased to zero at the
th cultivation hour. At this moment, the cultivation reached the
tationary growth phase (Fig. 1a). Thus, its consumption is directly
elated to cell growth. From Series A experiments amino acids were
nalyzed in order to estimate the speciﬁc amino acid yield factor
o conduct further assays (Fig. 2). Thus, the yield factor determined
or l-glutamic acid was Yx/glu = 0.5 g/g. l-Glicine (Yx/gli = 4.8 g/g)
nd l-arginine (Yx/arg = 28.3 g/g) were not limiting, since they were
eft over at the end of cultivation. l-Serine (Yx/ser = 32.1 g/g) and l-
isteine. HCl (Yx/cis = 78.4 g/g) could be limiting despite their small
onsumption, since they were not left over at the end of cultiva-
ion. The overall approximate relationship of carbon/nitrogen was
.1 g/g. Results obtained from Series B–D indicated that all amino
cids were left over at the end of cultivation in these experiments
data not shown). Therefore, these results suggest that the origi-
al Catlin medium composition must be reformulated in order to
nhance antigen production from the N. meningitidis serogroup B
ultivations.
OMV  were released after the stationary growth phase begin-
ing and, in almost assays, when all lactate was  consumed (Fig. 1b
nd c). In all assays, the electrophoresis patterns revealed the pres-
nce of class proteins (major proteins). Iron regulated proteins
IRP) and high molecular weight proteins (NadA) are observed
Fig. 3). In the electronic microscopy images obtained for Series
–D, the contour, tubular and spherical shapes, cited formerly by
ig. 4. (a) Electronic microscopy image of OMV  shapes (tubular and spherical) of N. meni
nitial concentrations of lactate and amino acids) at 20th cultivation hour; (b) OMV shapefrom  the corresponding cultivation hour. The representative bands of IRP expression
appearing  are between 70 and 108 kDa (indicated by arrows). The highest molecular
weight  bands indicate possible presence of NadA.
Devoe and Gilchrist [30], and the vesicle integrity were veriﬁed
(Fig. 4).
4.  Discussion
A  kinetic correlation was established between cell growth and
OMV production in cultivation of N. meningitidis serogroup B under
different conditions employing lactate as the main carbon source.
The growth of N. meningitidis requires pyruvate, or lactate, or glu-
cose as the sole source of carbon and during cultivation in any of
these carbon sources, secretion of acetate into the medium occurs
ngitidis B strain N 44/89 from experiment 5 of Series C (Catlin medium with double
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31]. Employment of glucose can promote larger cell productivity
ccording to a report by Fu et al. [32]. However, that study aimed
ainly biomass generation and the OMV  production was not inves-
igated. They employed a synthetic medium (MC6), altering the
riginal Catlin medium composition, with glucose as the main car-
on source and iron supplementation. At the end of cultivation,
hey obtained almost 10 g/L of dry biomass. In such conditions,
hey observed that the main metabolic pathways for assimilation
f the carbon source (glucose) would be Entner-Doudoroff (EDP),
hich would be responsible for about 80% of the consumption, and
entose-phosphate could have accounted for the remaining 20% of
he glucose metabolized. Fu et al. [32] did not observe any activity
f the Embden–Meyerhof–Parnas (EMP) pathway.
Recently Baart et al. [33,34] reported the modeling of N. menin-
itidis B metabolism at different speciﬁc growth rates in glucose
ultivation medium. However, the authors did not present quan-
itative values for OMV  production or the composition of their
rotein proﬁle. The study described the inﬂuence of the growth
ate of N. meningitidis on its macro-molecular composition and its
etabolic activity, which was determined in chemostat cultures.
n the applied range of growth rates, no signiﬁcant changes in RNA
ontent or in protein content with growth rate were observed in
. meningitidis. The DNA content of N. meningitidis was  somewhat
igher at the highest applied growth rate. The phospholipid and
ipopolysaccharide contents in N. meningitidis varied with growth
ate but no speciﬁc trends were identiﬁed. The cellular fatty acid
omposition and the amino acid composition did not vary signiﬁ-
antly with growth rate. Additionally, the PorA content in the OMV
as signiﬁcantly lower at the highest growth rate. The metabolic
uxes at different growth rates were calculated using ﬂux balance
nalysis. Errors in these calculations were detected using Monte
arlo Simulation. Thus the reliability of these calculated values of
ux distribution could be speciﬁed, which are not reported for this
ype of analysis. The yield of biomass on the substrate (Y(x/s)) and
he maintenance coefﬁcient (m(s)) were determined as 0.44 (±0.04)
/g and 0.04 (±0.02) g/(g h), respectively. The growth associated
nergy requirement (Y(x/ATP)) and the non-growth associated
TP requirement for maintenance (m(ATP)) were estimated 0.13
±0.04) mol/mol and 0.43 (±0.14) mol/mol h, respectively. These
uthors found the split ratio between the Entner–Doudoroff and
he pentose phosphate pathways. The pathways utilizing glucose
lone in N. meningitidis, had a minor effect on ATP formation rate
ut a major effect on the ﬂuxes going through, for instance, the
itric-acid cycle. Therefore, they presented ﬂux values in ranges
or the underdetermined parts of metabolic network rather than
resenting single values, which is the more common practice in
iterature.
The studies aiming biomass or OMV  production reported in pre-
ious literature and cited above were performed employing glucose
s principal carbon source, instead lactate as in the present study. So
o comparisons can be performed between them and the present
ne.
.1. OMV  production
The  empirical expression proposed by Luedeking & Piret [35]
as used for analysis of the main cultivation product. It relates the
peciﬁc product formation rate (P) with the speciﬁc growth rate
f microorganism (X) by the equation P = ˛·X + ˇ. This equation,
here  ˛ and  ˇ are empirical constants, indicates the existence of
wo mechanisms of production of the product. The ﬁrst is associ-
ted with bacterial growth (represented by ˛·X) while the other is
ndependent of the growth of microorganisms (represented by ˇ)
36]. A computer program (Logiciel du Lissage), based on polyno-
ial ﬁt by the Spline method [37] was employed for OMV  curve
tting and calculation of speciﬁc product formation rate. In the (2012) 6064– 6069
present  study, product formation is non-growth associated. The
values of  ˇ = P obtained for each assay are presented in Table 1.
Series C assays presented the highest values of ˇ, signifying the best
cultivation condition among those studied for production of OMV.
This ﬁnding conﬁrms that the strategy adopted for Series B
assays (original Catlin medium with lactate and amino acids pulse
at 6th cultivation hour) was  less efﬁcient than that adopted for
Series C cultivations (Catlin medium with double initial concentra-
tions of lactate and amino acids). The results showed that doubling
the initial concentrations of lactate and amino acids in Series C
assays did not promote any inhibitory effect in either growth or
OMV production (Fig. 1a–d). On the contrary, it stimulated cell
growth and OMV  production. It is possible to speculate about the
substrate storage capacity of cells. However, considering the severe
iron restriction imposed on cultivation experiments, a hypothesis
could be related with the larger residual quantities of iron present
on doubling the initial lactate and amino acids concentrations in
Series C experiments. If this limit on iron is less severe, small
additional residual iron quantities could be used to stimulate cell
growth kinetics and improve OMV  production without compromis-
ing the appropriate protein pattern. This hypothesis is proposed to
be studied in future experiments in order to further enhance Catlin
medium composition.
4.2.  Relationship between lactate consumption and OMV
production
The  growth of N. meningitidis requires pyruvate, or lactate, or
glucose as the sole source of carbon [31]. As far as lactic acid
consumption is concerned, there are three lactate-dehydrogenases
(LDHs)  responsible for the exclusive uptake of this carbon source.
In the presence of NAD+, the pyruvic acid produced by lactic
acid oxidation is then used for gluconeogenesis, which is stim-
ulated by lactic acid but inhibited by glucose. These three LDHs
are also involved in bacteria virulence determinants [38]. In addi-
tion, an NMR  and enzymatic study about carbon metabolism in
N. meningitidis has shown that consumption of glucose, lactic acid
and, especially, pyruvic acid, results in the excretion of signiﬁ-
cant amounts of acetic acid, via the phosphotransacetylase (PTA)
acetate kinase (ACK) pathway [39]. Thus, the employ of lactate,
which uptake is dependent to the LDHs activity and less associ-
ated to acetic acid formation, is most suitable for the culture of the
Neisseria meningitidis serogroup B aiming at production of OMV  for
antigen vaccine. The OMV  were released after the stationary phase
beginning and, in almost assays, when all the lactate has been con-
sumed (Fig. 1b and c). The preferential use of lactate as a carbon
source agrees with the report of Tettelin et al. [40], who described
the degradation of lactate by N. meningitidis B, its genome, and its
functions. In addition, according to Pollard and Frasch [41] lim-
iting the iron ion in Catlin medium is necessary to express the
iron-regulated proteins (IRP).
4.3. OMV constitution and protein pattern
In all experiments, the OMV  released contained IRP (Fig. 3) and
NadA, a high molecular weight protein. The antigenic function of
this protein was studied [8,42]; its presence could be considered a
suitable complementary characteristic among the antigen proper-
ties needed for vaccine production.
It is worth of mention that prior to being formulated into the
ﬁnal product the OMV  must be detoxiﬁed and analyzed for purity
(chemical determination and pyrogenicity) and for potency. In this
way, it is important to conﬁrm whether the OMV  obtained in
production process satisfy the criteria of constitution and protein






























































[S. Santos et al. / Vacc
Satisfying these criteria, the images obtained of all the series
nvestigated, the contour, tubular and spherical shapes, which were
ited formerly by Devoe and Gilchrist [30], and the vesicles integrity
ere conﬁrmed (Fig. 4).
. Conclusion
The highest values of the maximum concentration of OMV,
rodP, YP/X, and  ˇ were obtained in the experiments where the orig-
nal Catlin medium without iron supplementation was  formulated
ith double initial concentrations of lactate and amino acids and
he original glycerol concentration maintained. The results indi-
ated that lactate is the main source of carbon and the growth
imiting factor. Results of amino acids analysis suggested that the
riginal Catlin medium composition must be reformulated in order
o enhance antigen production from N. meningitidis B cultivations.
n all the experiments, glycerol was not consumed and could pro-
ect mechanically the released OMV. Further, the antigen (OMV)
oncentration in cultivation increased signiﬁcantly during the sta-
ionary growth phase. In all the experiments, vesicle integrity
as veriﬁed and the OMV  released contained IRP. Thus, the OMV
btained satisfy the constitution and protein pattern criteria and
re suitable for vaccine production. The cultivation medium com-
osition, the effect of residual iron on growth and OMV  production
ill be studied in future experiments.
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